
Sarepta Therapeutics Inc
SRPTNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$17.42
Day High
$17.99
Day Low
$17.42
Prev. Close
$17.30
VolumeShares traded today.
3.08M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$1.89B
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
164.40
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$43.92
52W LowLowest price over the past 52 weeks.
$10.42
50D MAAverage closing price over the last 50 trading days.
$20.08
200D MAAverage closing price over the last 200 trading days.
$19.96
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+5.4%1M
-13.5%6M
-7.6%YTD
-16.1%1Y
-52.5%About
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs.
www.sarepta.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade SRPT
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.